Cristina Borsilli, NP

NPI: 1629739131
Total Payments
$4,191
2024 Payments
$1,287
Companies
18
Transactions
279
Medicare Patients
771
Medicare Billing
$44,714

Payment Breakdown by Category

Food & Beverage$4,191 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,191 279 100.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,136 82 $0 (2024)
NESTLE HEALTHCARE NUTRITION INC. $968.92 48 $0 (2023)
Celgene Corporation $416.18 43 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $407.07 23 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $333.62 36 $0 (2024)
Ardelyx, Inc. $193.67 7 $0 (2024)
Janssen Biotech, Inc. $167.52 10 $0 (2024)
Gilead Sciences, Inc. $133.89 7 $0 (2024)
Merck Sharp & Dohme LLC $104.81 6 $0 (2023)
IRONWOOD PHARMACEUTICALS, INC $71.33 4 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,287 93 ABBVIE INC. ($495.70)
2023 $1,804 121 NESTLE HEALTHCARE NUTRITION INC. ($543.62)
2022 $1,101 65 Nestle HealthCare Nutrition Inc. ($425.30)

All Payment Transactions

279 individual payment records from CMS Open Payments — Page 1 of 12

Date Company Product Nature Form Amount Type
12/23/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $11.22 General
Category: Gastroenterology
12/18/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $6.48 General
Category: Gastroenterology
12/18/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $2.45 General
Category: Gastroenterology
12/11/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $2.14 General
Category: IMMUNOLOGY
11/21/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $23.13 General
Category: IMMUNOLOGY
11/19/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $1.47 General
Category: IMMUNOLOGY
11/18/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $29.75 General
Category: IMMUNOLOGY
11/12/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $16.79 General
Category: GI
10/29/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $13.57 General
Category: Immunology
10/28/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $31.08 General
Category: IMMUNOLOGY
10/21/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $19.62 General
Category: IMMUNOLOGY
10/16/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $22.16 General
Category: INTERNAL MEDICINE
10/09/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $8.88 General
Category: Gastroenterology
10/09/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $7.60 General
Category: Gastroenterology
10/09/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $5.61 General
Category: Gastroenterology
10/09/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $3.41 General
Category: Gastroenterology
10/08/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $34.32 General
Category: IMMUNOLOGY
10/08/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $0.53 General
Category: IMMUNOLOGY
10/04/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $11.02 General
Category: Gastroenterology
10/03/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $18.83 General
Category: Immunology
10/03/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $2.41 General
Category: GASTROENTEROLOGY
10/01/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $21.99 General
Category: INTERNAL MEDICINE
09/17/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $12.84 General
Category: INTERNAL MEDICINE
09/17/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $0.82 General
Category: INTERNAL MEDICINE
09/12/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $24.56 General
Category: IMMUNOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 347 485 $61,857 $21,976
2022 6 424 471 $62,280 $22,738
Total Patients
771
Total Services
956
Medicare Billing
$44,714
Procedure Codes
11

All Medicare Procedures & Services

11 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 126 212 $20,450 $6,627 32.4%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 90 130 $15,432 $6,477 42.0%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 56 58 $13,050 $4,689 35.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 58 66 $9,600 $2,780 29.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 17 19 $3,325 $1,403 42.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 198 229 $34,350 $12,920 37.6%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 107 108 $10,800 $3,719 34.4%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 38 49 $5,156 $2,114 41.0%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 20 20 $4,174 $1,706 40.9%
99231 Follow-up hospital inpatient care per day, typically 15 minutes Facility 2022 44 48 $4,400 $1,144 26.0%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 17 17 $3,400 $1,134 33.4%

About Cristina Borsilli, NP

Cristina Borsilli, NP is a Family healthcare provider based in Munster, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/06/2022. The National Provider Identifier (NPI) number assigned to this provider is 1629739131.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cristina Borsilli, NP has received a total of $4,191 in payments from pharmaceutical and medical device companies, with $1,287 received in 2024. These payments were reported across 279 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($4,191).

As a Medicare-enrolled provider, Borsilli has provided services to 771 Medicare beneficiaries, totaling 956 services with total Medicare billing of $44,714. Data is available for 2 years (2022–2023), covering 11 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location Munster, IN
  • Active Since 01/06/2022
  • Last Updated 01/21/2026
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1629739131

Products in Payments

  • ZENPEP (Drug) $857.08
  • RINVOQ (Biological) $658.62
  • ZEPOSIA (Drug) $389.22
  • ENTYVIO (Biological) $384.91
  • XIFAXAN (Drug) $293.94
  • SKYRIZI (Biological) $196.42
  • IBSRELA (Drug) $193.67
  • VOWST (Biological) $162.98
  • STELARA (Biological) $135.12
  • CREON (Drug) $129.78
  • DIFICID (Drug) $104.81
  • LINZESS (Drug) $102.46
  • Linzess (Drug) $71.33
  • DUPIXENT (Biological) $70.54
  • TRULANCE (Drug) $39.68
  • VOQUEZNA (Drug) $35.90
  • TREMFYA (Drug) $32.40
  • HUMIRA (Biological) $25.79
  • VIBERZI (Drug) $22.46
  • EOHILIA (Drug) $22.16

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Munster